Samsung Just Turned Your Watch Into a Blood-Pressure Monitor in the U.S.—But the Number on Your Wrist Can Be Wrong Unless You Do This One Boring Step
Samsung finally flipped on blood-pressure monitoring for Galaxy Watch owners in the U.S.—but the reading is only as trustworthy as your monthly cuff calibration. The “boring step” is the entire point: it reveals this is a cuff-dependent estimate, not a clinic-grade replacement.
By TheMurrow Editorial
April 8, 2026
Key Points
- 1Samsung began a phased U.S. rollout on March 31, 2026, enabling Galaxy Watch blood-pressure monitoring via Samsung Health Monitor.
- 2Calibrate with a third-party upper-arm cuff—three readings in 30 minutes—and repeat every 28 days or your wrist number can drift.
- 3Treat results as a structured log, not a diagnosis: follow prep rules, standardize posture, and bring trends to a clinician.
On March 31, 2026, Samsung quietly did something millions of Galaxy Watch owners have been hearing about for years: it began a phased rollout of blood-pressure monitoring in the United States. Not a new watch. Not a new sensor. A software switch—one that has been available in other markets, but long delayed here.
The moment matters because blood pressure is the most ordinary serious metric in modern medicine. People track steps for motivation, heart rate for curiosity, sleep for guilt. Blood pressure sits in a different category: it’s the number that gets you put on a medication, or taken off one. It’s the number that turns “feeling fine” into “you should see a doctor.”
Yet Samsung’s own framing is almost stubbornly modest. In its U.S. announcement, the company describes the feature as a health-and-wellness tool that offers “greater insight,” and says it is not intended to prevent or diagnose high blood pressure. The language is careful for a reason.
Because the real story isn’t that your watch can now “take your blood pressure.” The real story is the step Samsung requires before you can trust the number—and what that step tells us about where wearable health is headed.
“Samsung’s blood-pressure feature isn’t a cuff replacement. It’s a cuff-dependent estimate that lives on your wrist.”
— — TheMurrow Editorial
Samsung’s U.S. rollout: what changed on March 31, 2026—and who gets it
Samsung began a phased U.S. rollout on March 31, 2026 that enables blood-pressure monitoring on supported devices through the Samsung Health Monitor app, according to Samsung’s U.S. newsroom announcement. The practical upshot: eligible Galaxy Watch owners can measure and track systolic and diastolic blood pressure—along with heart rate—using the watch.
The rollout arrives after what multiple outlets describe as a years-long wait for U.S. availability, a delay widely attributed to the regulatory sensitivity around blood-pressure measurement. Forbes, for example, highlighted how long Samsung users have waited to see the feature arrive stateside—an implicit acknowledgment that blood pressure is not treated like a typical consumer wellness metric.
The rollout arrives after what multiple outlets describe as a years-long wait for U.S. availability, a delay widely attributed to the regulatory sensitivity around blood-pressure measurement. Forbes, for example, highlighted how long Samsung users have waited to see the feature arrive stateside—an implicit acknowledgment that blood pressure is not treated like a typical consumer wellness metric.
March 31, 2026
Samsung began a phased U.S. rollout enabling blood-pressure monitoring via the Samsung Health Monitor app on supported Galaxy Watch devices.
Compatibility: Galaxy Watch4 and later (not Galaxy Fit)
Samsung says the feature applies to Galaxy Watch4 and later models, and it excludes Galaxy Fit. Owners will also run into OS and app requirements, since the capability is delivered through Samsung Health Monitor rather than the more general Samsung Health app.
A phased rollout also means two people with the same watch model may not see the feature on the same day. That’s normal for major app-enabled changes, but it adds to the confusion in the early weeks: “Do I have it? Am I supposed to have it? Did I miss an update?” The answer, for many, will simply be: wait.
A phased rollout also means two people with the same watch model may not see the feature on the same day. That’s normal for major app-enabled changes, but it adds to the confusion in the early weeks: “Do I have it? Am I supposed to have it? Did I miss an update?” The answer, for many, will simply be: wait.
What you’re actually getting
Samsung positions blood-pressure monitoring as part of a broader set of health features that help users build routines and spot changes over time. Framing matters here. Samsung’s language is deliberate: insight, tracking, monitoring—while explicitly avoiding medical claims about diagnosis or prevention.
That’s not just corporate caution. It’s an admission that the feature’s usefulness depends heavily on how you use it—and on a separate tool you may have to buy.
That’s not just corporate caution. It’s an admission that the feature’s usefulness depends heavily on how you use it—and on a separate tool you may have to buy.
“The most important part of watch-based blood pressure is the part you can’t do with the watch.”
— — TheMurrow Editorial
The one “boring step” that makes the number meaningful: calibration (and the 28-day clock)
Samsung’s blood-pressure feature comes with a requirement that many people will find inconvenient—and that many will be tempted to ignore. You must calibrate the watch using a traditional upper-arm cuff blood-pressure monitor, and Samsung says you must repeat that calibration every 28 days.
That 28-day rule is the feature’s most revealing detail. It effectively tells users: the watch is not a self-sufficient blood-pressure instrument. It is an estimator whose accuracy depends on frequent reference to a cuff reading.
That 28-day rule is the feature’s most revealing detail. It effectively tells users: the watch is not a self-sufficient blood-pressure instrument. It is an estimator whose accuracy depends on frequent reference to a cuff reading.
Every 28 days
Samsung requires recurring recalibration of the watch’s blood-pressure estimates using an upper-arm cuff monitor.
What Samsung requires, specifically
Samsung’s support guidance lays out a calibration procedure with unusually tight constraints:
- Use a third-party upper-arm cuff blood-pressure monitor (sold separately).
- Take three cuff measurements within a 30-minute timeframe.
- Enter those readings into the Samsung Health Monitor app to calibrate.
- Repeat calibration every 28 days.
Those are not suggestions. Samsung describes calibration as required—both initially and on a recurring schedule.
- Use a third-party upper-arm cuff blood-pressure monitor (sold separately).
- Take three cuff measurements within a 30-minute timeframe.
- Enter those readings into the Samsung Health Monitor app to calibrate.
- Repeat calibration every 28 days.
Those are not suggestions. Samsung describes calibration as required—both initially and on a recurring schedule.
Calibration: the required workflow
- 1.Use a third-party upper-arm cuff blood-pressure monitor (sold separately).
- 2.Take three cuff measurements within a 30-minute timeframe.
- 3.Enter those readings into the Samsung Health Monitor app to calibrate.
- 4.Repeat calibration every 28 days.
The prep rules most people break (and why they matter)
Samsung also provides practical guidance to improve calibration and measurement quality. In plain terms: treat it like a real blood-pressure reading, not a quick gadget demo.
Samsung advises avoiding several common factors for 30 minutes before measuring:
- Smoking
- Bathing
- Exercise
- Alcohol
- Caffeine
Then, for the actual measurement environment and posture, Samsung recommends:
- Sit indoors in a quiet area
- Keep back supported
- Keep legs uncrossed and feet flat
- Rest arms on a table
- Rest 5 minutes before measuring
- Wear the watch snugly and use the same wrist consistently
Those details can sound finicky until you remember what blood pressure does in the real world: it swings with stress, exertion, caffeine, posture, even the simple act of talking. Calibration isn’t a setup chore. It’s the foundation under the watch’s estimate.
Samsung advises avoiding several common factors for 30 minutes before measuring:
- Smoking
- Bathing
- Exercise
- Alcohol
- Caffeine
Then, for the actual measurement environment and posture, Samsung recommends:
- Sit indoors in a quiet area
- Keep back supported
- Keep legs uncrossed and feet flat
- Rest arms on a table
- Rest 5 minutes before measuring
- Wear the watch snugly and use the same wrist consistently
Those details can sound finicky until you remember what blood pressure does in the real world: it swings with stress, exertion, caffeine, posture, even the simple act of talking. Calibration isn’t a setup chore. It’s the foundation under the watch’s estimate.
30 minutes before measuring: avoid
- ✓Smoking
- ✓Bathing
- ✓Exercise
- ✓Alcohol
- ✓Caffeine
During measurement: posture and setup
- ✓Sit indoors in a quiet area
- ✓Keep back supported
- ✓Keep legs uncrossed and feet flat
- ✓Rest arms on a table
- ✓Rest 5 minutes before measuring
- ✓Wear the watch snugly and use the same wrist consistently
What the Galaxy Watch is measuring—and what it is not
Samsung says the watch estimates blood pressure by using its internal sensors and calibration data. In its U.S. announcement, Samsung describes a system that “calibrates values and blood pressure changes to estimate your blood pressure” and reports that it can provide systolic, diastolic, and heart rate readings using the watch’s internal heart-rate monitoring sensors.
That phrasing—estimate, changes, calibrates—matters. It signals a model-based approach rather than the physical, pressure-based measurement that a cuff performs.
That phrasing—estimate, changes, calibrates—matters. It signals a model-based approach rather than the physical, pressure-based measurement that a cuff performs.
Manual spot checks, not continuous blood-pressure monitoring
Consumer coverage has emphasized a key practical point: this is not a continuous background metric. It’s a manual spot-check workflow—you decide when to measure, then follow the on-screen steps.
Tom’s Guide underscored another nuance: Samsung’s approach differs from the way other platforms frame high-blood-pressure insights. The point isn’t that one is “better,” but that they are not the same kind of promise. One offers a calibrated estimate when you ask for it; another may focus on alerting or pattern detection in different ways. The consumer takeaway: don’t assume the wrist number will behave like a clinic reading, and don’t assume it will function as a passive warning system.
Tom’s Guide underscored another nuance: Samsung’s approach differs from the way other platforms frame high-blood-pressure insights. The point isn’t that one is “better,” but that they are not the same kind of promise. One offers a calibrated estimate when you ask for it; another may focus on alerting or pattern detection in different ways. The consumer takeaway: don’t assume the wrist number will behave like a clinic reading, and don’t assume it will function as a passive warning system.
Manual spot-check
Samsung’s blood-pressure feature is initiated by the user for single readings, rather than continuously tracking blood pressure in the background.
A useful tool—if you treat it like one
Wearable blood-pressure estimates can still be valuable in real life, particularly for:
- Building a routine around measurements
- Observing directional changes after lifestyle adjustments
- Sharing a log with a clinician as supplementary context
But the watch is only as good as the habits around it. The calibration requirement isn’t just a limitation; it’s an honest description of the system.
- Building a routine around measurements
- Observing directional changes after lifestyle adjustments
- Sharing a log with a clinician as supplementary context
But the watch is only as good as the habits around it. The calibration requirement isn’t just a limitation; it’s an honest description of the system.
“If you want medical-grade certainty, you still need medical-grade behavior.”
— — TheMurrow Editorial
The regulatory tightrope: “FDA-cleared,” “FDA-approved,” or neither?
Public conversations about wearables often collapse into a single question: “Is it FDA-approved?” The uncomfortable answer is that this phrase is both overused and often imprecise.
Samsung’s own U.S. press release draws a noticeable distinction. It describes other Galaxy Watch features—such as Sleep Apnea and ECG/irregular rhythm notifications—as FDA authorized/cleared, but it does not describe blood-pressure monitoring in the same terms. Instead, Samsung repeatedly frames blood pressure as a health-and-wellness feature and includes the explicit disclaimer that it is not intended to prevent or diagnose high blood pressure.
That omission is not a footnote. It’s the heart of the matter.
Samsung’s own U.S. press release draws a noticeable distinction. It describes other Galaxy Watch features—such as Sleep Apnea and ECG/irregular rhythm notifications—as FDA authorized/cleared, but it does not describe blood-pressure monitoring in the same terms. Instead, Samsung repeatedly frames blood pressure as a health-and-wellness feature and includes the explicit disclaimer that it is not intended to prevent or diagnose high blood pressure.
That omission is not a footnote. It’s the heart of the matter.
Conflicting headlines—and why readers should be cautious
Some reporting has characterized the U.S. rollout as “FDA-approved blood pressure tracking.” Tech Advisor used phrasing along those lines, which may reflect a misunderstanding or a shorthand that doesn’t match Samsung’s careful wording.
Meanwhile, SamMobile reports that Samsung has clarified blood-pressure monitoring in the U.S. is not FDA-approved and is treated as a wellness feature, citing a statement Samsung provided to Android Authority. That aligns more closely with the language in Samsung’s own announcement.
If you care about the distinction, the safest stance is the simplest: Samsung has released the feature in the U.S., but it is positioned as wellness rather than as an FDA-cleared medical function. Without explicit FDA documentation or explicit Samsung claims of clearance, readers should resist confident declarations either way.
Meanwhile, SamMobile reports that Samsung has clarified blood-pressure monitoring in the U.S. is not FDA-approved and is treated as a wellness feature, citing a statement Samsung provided to Android Authority. That aligns more closely with the language in Samsung’s own announcement.
If you care about the distinction, the safest stance is the simplest: Samsung has released the feature in the U.S., but it is positioned as wellness rather than as an FDA-cleared medical function. Without explicit FDA documentation or explicit Samsung claims of clearance, readers should resist confident declarations either way.
Key Insight
If you’re trying to interpret the regulatory status, follow Samsung’s own wording: blood pressure is framed as wellness in the U.S. announcement, not as an explicitly FDA-cleared medical feature.
Why “wellness” positioning is attractive—and increasingly complicated
The FDA has a formal policy framework for general wellness products that are considered low risk. That framework has historically provided a way for consumer tech to offer health-adjacent functionality without stepping fully into medical-device territory.
But legal analysis of the FDA’s updated general wellness guidance (updated January 6, 2026) suggests the agency has taken a firmer view that blood pressure measurement or estimation is inherently connected to conditions like hypertension and hypotension—often pushing products toward medical-device regulation. That tension helps explain Samsung’s careful, hedged language.
But legal analysis of the FDA’s updated general wellness guidance (updated January 6, 2026) suggests the agency has taken a firmer view that blood pressure measurement or estimation is inherently connected to conditions like hypertension and hypotension—often pushing products toward medical-device regulation. That tension helps explain Samsung’s careful, hedged language.
Jan 6, 2026
The FDA’s updated general wellness guidance is described as taking a firmer view on blood pressure estimation, complicating “wellness” positioning.
What this means for users: who benefits, who should be skeptical
The promise of blood-pressure tracking on a watch is seductive: effortless awareness, constant insight, fewer doctor visits. The reality, at least in Samsung’s implementation, is more measured—and that’s not necessarily a flaw.
Case study: the “newly serious” user
Consider a common scenario. Someone in their 40s buys a Galaxy Watch for fitness tracking. During a routine physical, their clinician flags elevated blood pressure and recommends home monitoring. Suddenly, that wrist feature looks less like a curiosity and more like a daily ritual.
For that user, the watch can help in practical ways:
- It lowers friction: the measurement tool is already on the body.
- It supports habit formation: reminders and logs live in the same ecosystem.
- It provides trend context: readings can be tracked over time.
But the user still needs an upper-arm cuff and still has to do the three measurements in 30 minutes calibration process—and repeat it every 28 days. The watch may help with compliance, but it doesn’t replace the clinical anchor.
For that user, the watch can help in practical ways:
- It lowers friction: the measurement tool is already on the body.
- It supports habit formation: reminders and logs live in the same ecosystem.
- It provides trend context: readings can be tracked over time.
But the user still needs an upper-arm cuff and still has to do the three measurements in 30 minutes calibration process—and repeat it every 28 days. The watch may help with compliance, but it doesn’t replace the clinical anchor.
Case study: the “optimization” user
Another scenario: a healthy user wants to test how coffee, stress, and sleep affect their body. The watch can offer a structured way to observe changes—assuming the user follows Samsung’s prep rules, including the 30-minute avoidance window for caffeine and alcohol and the 5-minute rest before measuring.
The risk here isn’t medical harm so much as misguided confidence. A single reassuring reading can become permission to ignore a pattern. A single alarming reading can spark unnecessary anxiety. Blood pressure punishes both overconfidence and panic.
The risk here isn’t medical harm so much as misguided confidence. A single reassuring reading can become permission to ignore a pattern. A single alarming reading can spark unnecessary anxiety. Blood pressure punishes both overconfidence and panic.
Who should be most cautious
Anyone who is likely to treat a wrist estimate as clinical truth should slow down. Samsung’s own disclaimers are blunt for a reason: the feature isn’t intended to diagnose. It can inform, but it can also mislead when used casually—especially if calibration lapses beyond the 28-day window.
The “data gap” problem: wearables generate numbers; clinicians need context
Wearables produce an abundance of health data. Clinical care, by contrast, depends on context: conditions, medications, measurement conditions, and repeatability.
Blood pressure is a perfect example of the mismatch. A watch reading without calibration history, posture details, timing, or prep conditions can be worse than no data at all. It looks authoritative and travels easily—screenshots, shared graphs, anxious text messages—without the discipline that makes blood pressure meaningful.
Blood pressure is a perfect example of the mismatch. A watch reading without calibration history, posture details, timing, or prep conditions can be worse than no data at all. It looks authoritative and travels easily—screenshots, shared graphs, anxious text messages—without the discipline that makes blood pressure meaningful.
Practical takeaways for making the feature actually useful
If you plan to use Samsung’s blood-pressure monitoring, treat it like a protocol rather than a party trick:
- Buy a validated upper-arm cuff and keep it accessible. Calibration requires it, and Samsung explicitly calls for an upper-arm device.
- Calendar the 28-day recalibration. Missing the window invites drift.
- Standardize your routine. Same wrist, snug fit, quiet space, back supported, feet flat.
- Respect the 30-minute prep rule. Caffeine and exercise are not minor variables.
- Use the readings as a log, not a verdict. Bring trends to a clinician; don’t self-diagnose.
Wearable blood-pressure tracking can be a bridge between the clinic and everyday life. It works best when you stop asking for a magic number and start building a repeatable measurement habit.
- Buy a validated upper-arm cuff and keep it accessible. Calibration requires it, and Samsung explicitly calls for an upper-arm device.
- Calendar the 28-day recalibration. Missing the window invites drift.
- Standardize your routine. Same wrist, snug fit, quiet space, back supported, feet flat.
- Respect the 30-minute prep rule. Caffeine and exercise are not minor variables.
- Use the readings as a log, not a verdict. Bring trends to a clinician; don’t self-diagnose.
Wearable blood-pressure tracking can be a bridge between the clinic and everyday life. It works best when you stop asking for a magic number and start building a repeatable measurement habit.
Make the reading worth keeping
Buy a validated upper-arm cuff for calibration.
Calendar the 28-day recalibration.
Standardize routine: same wrist, snug fit, quiet space.
Follow the 30-minute prep rule and rest 5 minutes.
Treat readings as a log to discuss with a clinician—not a diagnosis.
Calendar the 28-day recalibration.
Standardize routine: same wrist, snug fit, quiet space.
Follow the 30-minute prep rule and rest 5 minutes.
Treat readings as a log to discuss with a clinician—not a diagnosis.
Where wrist blood pressure goes next—and what Samsung’s approach signals
Samsung’s U.S. rollout is noteworthy not only because it finally happened, but because of how it happened. The feature comes with a recurring calibration mandate and careful disclaimers. Samsung is effectively saying: the wrist can be a window, but not a courtroom.
That stance may frustrate users who wanted a cuff-free future. It may also be the most responsible version of watch-based blood pressure available at consumer scale right now. A calibrated estimator is less glamorous than a “medical device on your wrist,” but it’s also more honest about the limits of optical sensors, variability, and the realities of blood pressure itself.
Wearable health has entered its more serious era. The novelty phase is ending. The questions now are about trust, standards, and what companies will claim—especially in a U.S. environment where the line between wellness and medical device is both lucrative and legally consequential.
Samsung’s move adds a powerful tool to millions of wrists. It also adds a quiet reminder: if you want reliable health data, you don’t just need better sensors. You need better rituals.
That stance may frustrate users who wanted a cuff-free future. It may also be the most responsible version of watch-based blood pressure available at consumer scale right now. A calibrated estimator is less glamorous than a “medical device on your wrist,” but it’s also more honest about the limits of optical sensors, variability, and the realities of blood pressure itself.
Wearable health has entered its more serious era. The novelty phase is ending. The questions now are about trust, standards, and what companies will claim—especially in a U.S. environment where the line between wellness and medical device is both lucrative and legally consequential.
Samsung’s move adds a powerful tool to millions of wrists. It also adds a quiet reminder: if you want reliable health data, you don’t just need better sensors. You need better rituals.
T
About the Author
TheMurrow Editorial is a writer for TheMurrow covering health & wellness.
Frequently Asked Questions
When did Samsung enable blood-pressure monitoring in the U.S.?
Samsung began a phased U.S. rollout on March 31, 2026, enabling blood-pressure monitoring for supported Galaxy Watch models through the Samsung Health Monitor app. Because it’s phased, availability can differ by user and device even within the same model family.
Which Galaxy Watches support blood-pressure monitoring?
Samsung says the feature applies to Galaxy Watch4 and later models. The rollout does not include Galaxy Fit. You may also need to meet specific OS/app requirements, since the feature runs through Samsung Health Monitor rather than Samsung Health alone.
Do I need a blood-pressure cuff if I have the watch feature?
Yes. Samsung requires calibration using a third-party upper-arm cuff monitor (sold separately). The watch’s readings depend on that calibration, and Samsung’s guidance does not describe wrist-cuff calibration—only upper-arm cuff devices.
How often do I have to calibrate the Galaxy Watch for blood pressure?
Samsung states calibration is required initially and then every 28 days. Calibration involves taking three cuff measurements within 30 minutes and entering them into the Samsung Health Monitor app. If you let calibration lapse, the usefulness of the watch estimate can degrade.
Is Samsung’s blood-pressure monitoring FDA-approved or FDA-cleared?
Samsung’s U.S. announcement does not describe blood-pressure monitoring as FDA cleared/authorized in the way it describes some other features. Reporting from SamMobile says Samsung has clarified it is not FDA-approved and is positioned as a wellness feature. Readers should be cautious with headlines that claim otherwise without documentation.
Is the watch measuring blood pressure continuously?
No. Coverage describes it as a manual spot-check workflow rather than continuous monitoring. You initiate a measurement, follow the steps, and record the reading. It’s best treated as a structured way to log estimates over time—not as a passive, always-on blood-pressure monitor.
